Importance of the field: Sjögren's syndrome (SS) is an autoimmune epithelitis. This
exocrinopathy is frequently associated with extraglandular complications, and the patients …

At present, there is no treatment capable of modifying the evolution of Sjögren's syndrome
(SS) and the therapeutic approach is based mainly on symptomatic replacement or …

Primary Sjögren's syndrome is a systemic autoimmune disease characterized by
progressive exocrine gland destruction, resulting clinically in eyes and mouth dryness. To …

Introduction Sjögren's syndrome (SS) is an immune-mediated inflammatory condition
characterized by sicca syndrome, musculoskeletal pain, and fatigue. Extra-glandular …

Opinion statement Primary Sjögren's syndrome (pSS) is an autoimmune disease, showing a
broad heterogeneity concerning the symptoms, the involved organs, as well as the …

The management of patients with primary Sjogren syndrome (pSS) has long suffered from
the lack of effective treatments. Progress made in the understanding of pSS pathogenesis …

Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease characterised by
xerostomia and xerophthalmia. In at least one-third of patients, the disease may be …

Primary Sjögren's Syndrome (pSS) is characterized by focal lymphocytic infiltration of
secretory exocrine glands associated with severe dryness of eyes and mouth in particular …

Sjögren's syndrome (SS) is a systemic autoimmune disease that mainly affects the exocrine
glands and usually presents as persistent dryness of the mouth and eyes. SS primarily …

Sjögren's syndrome is a systemic inflammatory rheumatic disorder of unknown origin with so
far inadequate therapy options. Management of Sjögren's syndrome is still primarily …